-
Ciprofloxacin Hydrochloride Assay Workflow
2026-09-02
This scenario-based guide explains how Ciprofloxacin (hydrochloride), SKU C5539, can support controlled antibacterial, combination, and cell-based assay workflows. It connects mechanism, solution preparation, cross-domain interpretation, and vendor selection to practical laboratory decisions.
-
Lipid Peroxidation (MDA) Assay Kit Guide
2026-09-01
Quantify malondialdehyde across tissues, cells, and biofluids with a dual-readout workflow built for oxidative stress and ferroptosis research. This guide shows how to pair MDA measurements with orthogonal endpoints, control matrix effects, and translate findings from doxorubicin-induced liver injury studies into reproducible experiments.
-
A40926: From Fermentation to Assay Insight
2026-09-01
A40926 is a dalbavancin precursor whose biosynthetic engineering offers practical lessons for assay design. This evidence-based guide connects strain optimization, cell-wall pharmacology, MIC interpretation, and translational antibacterial research.
-
Qushi Huoxue Ointment in MASLD: Mechanistic Study
2026-08-31
A 2026 World Journal of Hepatology study reports that Qushi Huoxue ointment reduced steatosis and inflammatory injury in a mouse model of metabolic associated steatotic liver disease by coordinating autophagy activation with ferroptosis suppression. Its integrated use of serum LC-MS/MS, network pharmacology, molecular validation, and electron microscopy provides a useful mechanistic framework, although causal and clinical validation remain necessary.
-
D-N-Acetylgalactosamine: Practical Lab Guide
2026-08-31
D-N-Acetylgalactosamine provides a defined, water- or DMSO-soluble reagent for glycoprotein and glycosylation studies, including brain heteropolysaccharides analysis. It should not be selected for ethanol-based workflows or long-term storage of prepared solutions, and application-specific validation is required because no directly matched paper evidence is supplied here.
-
WEHI-539: A Selective BCL-XL Inhibitor Workflow
2026-08-30
WEHI-539 provides a mechanistically focused way to test whether cell survival depends on BCL-XL rather than applying a nonspecific cytotoxic challenge. This guide connects apoptosis assays, MCL-1 interaction studies, glioblastoma models, and cancer stem cell sensitization with practical workflow and troubleshooting advice.
-
Cisplatin Beyond Cytotoxicity: A Renal Toxicity Lens
2026-08-29
Cisplatin is more than a DNA-damaging anticancer tool: its renal effects can reveal how acute injury progresses toward inflammation and fibrosis. This guide integrates CDDP chemistry, assay design, and SMYD2-based mechanistic insights for more informative cancer research.
-
PFOS Injury in HK-2 Cells: Ferroptosis and ER Stress
2026-08-28
The reference study links perfluorooctane sulfonate exposure to human kidney tubular-cell injury through coordinated ferroptosis and endoplasmic reticulum stress responses. Its integrated biomarker strategy provides a mechanistic framework for studying PFOS nephrotoxicity and evaluating pathway-directed interventions.
-
Lanabecestat (AZD3293) in BACE1 Research
2026-08-28
Lanabecestat (AZD3293) enables controlled BACE1 enzyme inhibition in neuronal models, helping researchers connect amyloid-beta production inhibition with functional synaptic measurements. This workflow-focused guide shows how to model partial inhibition, preserve assay interpretability, and troubleshoot discordant amyloid and electrophysiology results.
-
Staurosporine Beyond Apoptosis: A Translational Lens
2026-08-27
Staurosporine is more than a canonical apoptosis tool: its broad kinase activity can reveal how impending cell death reshapes tumor-cell behavior, ER stress, cytokine signaling, and angiogenic potential. This article outlines a translational workflow for using Staurosporine to distinguish cytotoxicity from prometastatic survivor-state biology.
-
Necrostatin 2 (Nec-2) Assay Workflows
2026-08-27
Necrostatin 2 (Nec-2) provides a temporally controllable way to test RIPK2-linked cell-death signaling alongside membrane-repair and inflammatory readouts. This guide translates findings from Kupffer-cell Listeria research into practical assay design, concentration scouting, controls, and troubleshooting for necroptosis inhibition and ischemic stroke research.
-
Spinosad, CHRNA5, and EGFR Signaling in LUAD
2026-08-26
A 2024 study identifies spinosad as an inhibitor of lung adenocarcinoma proliferation and connects its activity to disruption of the CHRNA5–EGFR signaling axis. Transcriptomic, protein-interaction, cellular, and animal experiments suggest a mechanism involving G1 arrest, apoptosis, and improved response to gefitinib.
-
β-Elemene: Mechanisms and Research Workflows
2026-08-26
β-Elemene, also called Levo-β-elemene in some research contexts, is a C15H24 sesquiterpene studied in apoptosis, metabolism, neuroprotection, and inflammation. Primary cell evidence shows that β-elemene can inhibit MDI-induced adipogenesis in 3T3-L1 cells while influencing AMPK signaling, but these findings remain model- and concentration-dependent.
-
Fasudil (HA-1077) HCl: ROCK Workflow Guide
2026-08-25
Build reproducible ROCK-pathway experiments with Fasudil (HA-1077) HCl across cancer, migration, apoptosis, and pathway-crosstalk models. This practical guide connects dose design, orthogonal readouts, and Hippo-pathway assay logic while separating established evidence from testable extensions.
-
Kidney Progenitor Assembloids Model Renal Disease
2026-08-25
Huang and colleagues developed spatially patterned mouse and human kidney progenitor assembloids that recreate key self-assembly events between nephron and collecting-system progenitors. The resulting models improve cellular organization, maturation, function, and modeling of PKD2-associated polycystic kidney disease compared with conventional kidney organoids.